← Leaderboards
Jomy George
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Oral”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$236,409,338
- Judith S. Currier · University Of California Los Angeles$134,347,732
- Constance Ann Benson · University Of California, San Diego$123,741,444
- Wafaa M. El-Sadr · Columbia University Health Sciences$92,413,650
- Myron S Cohen · Family Health International$91,263,426
- Robert A Wood · Johns Hopkins University$57,641,510
Research focus
OralDoseHalf-LifeArea Under CurvePharmaceutical PreparationsAnti-Retroviral AgentsPlasmaHealthy VolunteerDrug KineticsOpportunistic InfectionsTranslatingSafetyRegimenOpen LabelAntiretroviral TherapyLaboratoriesDrug InteractionsHiv SeronegativityAlternative TreatmentAdherenceCoagulation ProcessActive MethodAreaAfrica
Grant awards (16)
Impact of steady state Cobicistat and Darunavir/Cobicistat And on the Pharmacokinetics And Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) In Healthy Volunteers (CLOTRX)$0
ZIA · FY2023 · CL · contact PI
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Phar$0
ZIA · FY2021 · CL · contact PI
Impact of steady state Cobicistat and Darunavir/Cobicistat And on the Pharmacokinetics And Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) In Healthy Volunteers (CLOTRX)$0
ZIA · FY2021 · CL · contact PI
Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted with Cobicistat in Healthy Volunteers (R2D2)$0
ZIA · FY2021 · CL · contact PI
Impact of Weekly Administration of RPT and INH on TAF Pharmacokinetics in Healthy Volunteers$0
ZIA · FY2021 · CL · contact PI
Impact of Weekly Administration of RPT and INH on TAF Pharmacokinetics in Healthy Volunteers$0
ZIA · FY2020 · CL · contact PI
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Phar$0
ZIA · FY2020 · CL · contact PI
Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted with Cobicistat in Healthy Volunteers (R2D2)$0
ZIA · FY2020 · CL · contact PI
Impact of steady state Cobicistat and Darunavir/Cobicistat And on the Pharmacokinetics And Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) In Healthy Volunteers (CLOTRX)$0
ZIA · FY2020 · CL · contact PI
Impact of Weekly Administration of RPT and INH on TAF Pharmacokinetics in Healthy Volunteers$0
ZIA · FY2019 · CL · contact PI
Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted with Cobicistat in Healthy Volunteers (R2D2)$0
ZIA · FY2019 · CL · contact PI
Impact of steady state Cobicistat and Darunavir/Cobicistat And on the Pharmacokinetics And Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) In Healthy Volunteers (CLOTRX)$0
ZIA · FY2019 · CL · contact PI
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Phar$0
ZIA · FY2019 · CL · contact PI
Impact of Weekly Administration of RPT and INH on TAF Pharmacokinetics in Healthy Volunteers$0
ZIA · FY2018 · CL · contact PI
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Phar$0
ZIA · FY2018 · CL · contact PI
Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted with Cobicistat in Healthy Volunteers (R2D2)$0
ZIA · FY2018 · CL · contact PI